Using Vanrx Workcells, pharmaceutical companies can bring injectable medicines to market faster. Short changeover times and flexible systems enable agile manufacturing.
Deloitte, an international financial advisory firm, has named Vanrx Pharmasystems as the fastest growing technology company in Canada on its 2018 Technology Fast 50 list. The Fast 50 program celebrates innovation in the form of rapid revenue growth. Vanrx’s revenue growth percentage was 19,342%, placing it first on the overall list.Read More
Aseptic Filling for Personalized Medicines describes a new solution for the aseptic filling of cell and gene therapies, immuno-oncology, mRNA and other modalities where manufacturing creates a therapy for a single patient.Download the white paper
This article focuses on syringe fill-finish challenges pharmaceutical companies are experiencing with complex biologics, including drug stability, plunger placement techniques, syringe and plunger formats. It explains the need for a highly accurate, precise, and repeatable syringe filling process.Read More
In a June 2018 interview with McKinsey & Company, Esteban Santos, executive vice president for operations at Amgen, described the current state of the biopharma market and the resulting need for companies to bring new drug products to market faster. This blog will explore how Vanrx’s aseptic processing machines can accelerate drug development, build facilities faster and respond faster to changing market conditions.Read More
Singota Solutions recognized a gap in the market for contract aseptic filling services. They realized that companies developing new drug products and needing to fill batches of 20,000 units or less were underserved by contract manufacturing organizations. They chose Vanrx’s SA25 Aseptic Filling Workcell to provide an agile filling service for vials, syringes and cartridges, with short lead times.Read the case study
Vanrx was recently featured in the leading international publication Cleanroom Technology for redesigning the aseptic filling process with our gloveless isolator technology. This article explains how the future of aseptic filling is shifting away from glove ports / conventional isolators and focusing on gloveless isolators, such as Vanrx Aseptic Filling Workcells. The built-in flexibility and aseptic assurance provided by these new aseptic filling technologies are a global solution for changing pharmaceutical market demands.Read More
Manual aseptic processing is definitely not the best approach— it’s the last resort. Vanrx would go a step further and suggest that manual aseptic processing should end. The technologies and process understanding exist to do away with operator-driven aseptic technique.Read More
Dec 10 - Dec 12, 2018
Huntington Beach, CA, USA
Mar 11 - Mar 13, 2019
San Diego, CA, USA
Mar 11 - Mar 14, 2019
Santa Clara, CA, USA
Get a detailed view of how Aseptic Filling Workcells compare to conventional technologies and help bring drug products to market faster.Download the white paper
Our team members have developed and brought complex drug products to market. We know what you need now, and are designing for the future.